BioSpace News Archive

Albany NY, United States: The healthcare clinical analytics market is prognosticated to observe considerable growth on the back of numerous factors.

The demand within the global market for elder care services has been rising on account of advancements in the geriatric section within healthcare.

Growing awareness regarding warts and their treatment is helping the global warts therapeutics market take on a high growth curve.

NeonMind Biosciences Inc. announced today a strategic partnership with BioScript Solutions, a Canadian leader in specialty care.

LumiThera Inc today announced the completion of its acquisition of Diopsys, Inc., a leader in modern visual electrophysiology medical devices that help eye care professionals analyze the entire visual pathway for visual and neuro-visual disorders.

Life Time Group Holdings, Inc. (“Life Time” or the “Company”) (NYSE: LTH) today announced that its financial results for the fourth quarter and full-year fiscal 2021 will be released before market open on Thursday, March 10, 2022.

Allergy Therapeutics plc, the fully integrated commercial biotechnology company specialising in allergy vaccines, announces its unaudited interim results for the six months ended 31 December 2021.

First Wave BioPharma, Inc., announced today that an abstract entitled, “Niclosamide Enemas, A Safe And Effective Treatment In Mild To Moderate Ulcerative Proctitis/Proctosigmoiditis.

AnPac Bio-Medical Science Co., Ltd. announced that its fully owned biochip subsidiary, Changwei System Technology Co., Ltd., was recently evaluated and appraised by China Alliance Appraisal Co. Ltd., an independent company that is certified and licensed by the China Appraisal Society under the Ministry of Finance and is one of the top 10 appraisers in China by revenue.

TELA Bio, Inc today announced the commercial launch of its SiteGuard No Rinse Antimicrobial Solution for use in plastic reconstructive surgery.